US Patent 10266592 Drug regulated transgene expression
Patent 10266592 was granted and assigned to Seattle Children's on April, 2019 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10266592 Drug regulated transgene expression
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
